The usefulness of L-carnitine supplementation in hemodialysis patients

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: (1) Intravenous L‐carnitine 20 mg/kg administration after each hemodialysis for 6 months (2) Wash out for 3months (3) Intravenous saline administration after each hemodialysis for 6months (1) Intravenous saline administration after each hemodialysis for 6months (2) Wash out for 3months (3) Intravenous L‐carnitine 20 mg/kg administration after each hemodialysis for 6 months CONDITION: hemodialysis patients (chronic kidney disease) PRIMARY OUTCOME: improvement of cardiac function, anemia and exercise tolerance INCLUSION CRITERIA: hemodialisys patients
Epistemonikos ID: d86ac91302c074b7236cddc43ae35d131dc3eaab
First added on: Aug 22, 2024